 When searching for big rewards, look no further than biotech stocks.Just be prepared for big risk, too.Biotechs offer gobs of price potential. Thats because unlike many companies that can slowly but steadily build up their businesses over time, the survival of biotechnology companies especially early on hinges on just a few trials of their developing treatments. Eventual approval of the drug means life-sustaining revenues for the company, so positive trial news can send shares skyrocketing. Setbacks, however, can spark an exodus.While its impossible for regular investors to gauge whats going on in testing labs, you can give yourself a small leg up by paying attention to the analysts who cover the biotechnology industry. If you find a stock thats mostly surrounded by bulls, that might be a signal that something rewarding is around the bend.Here are five biotech stocks that have a Strong Buy consensus analyst rating and have potential catalysts right around the corner. Weve used TipRanks Smart Score system to identify this health-care short list. Also remember that biotechnology stocks come with a considerable amount of risk, and that sharp drops are not uncommon. Consider using only a small allocation from the portion of your portfolio dedicated to aggressive investments. SEE ALSO: 10 High-Quality, High-Growth Stocks to Buy 